Login
Résultat de la recherche (1-20 par 91)Download
|
Symbol
|
KYCWDU | RMA2NV | OSLRCH | KYUADU | ABICTQ | RMBQ5V | KZEHDU | PELRCH | MCAPJB | KZFDDU | ABRBTQ | RMBQBV | KZJVDU | CJWBKB | PHTRCH | RMBAIV | ACBBSQ | PLSRCH | ABYHTQ | Z0ARGZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly & Co. / Merck & Co. Inc. | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Merck & Co. / Pfizer | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS-SPONS ADR / Sandoz Group AG / Vertex Pharmaceuticals Inc. | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Johnson & Johnson / Pfizer Inc. / UnitedHealth Group Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | Bristol Myers / Eli Lilly / Pfizer |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
05.06.2026 | 23.06.2026 | 19.08.2026 | 18.09.2026 | 05.05.2026 | 17.11.2026 | 20.11.2026 | 08.05.2026 | 21.05.2026 | 30.11.2026 | 10.06.2026 | 01.06.2026 | 30.12.2026 | 05.06.2026 | 09.06.2026 | 30.12.2026 | 30.06.2026 | 13.07.2026 | 21.07.2026 | 03.09.2026 |
| Demande | - | 99,80 | 31,230 | - | 35,700 | 39,500 | 38,450 | 35,200 | - | - | 34,240 | - | 35,600 | 36,380 | 35,100 | 46,900 | 43,830 | 41,960 | 47,390 | - |
| Offre | - | 100,60 | - | - | - | - | 39,450 | - | - | - | - | - | - | - | - | - | - | - | - | - |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)